Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Focal therapy in prostate cancer-report from a consensus panel.

de la Rosette J, Ahmed H, Barentsz J, Johansen TB, Brausi M, Emberton M, Frauscher F, Greene D, Harisinghani M, Haustermans K, Heidenreich A, Kovacs G, Mason M, Montironi R, Mouraviev V, de Reijke T, Taneja S, Thuroff S, Tombal B, Trachtenberg J, Wijkstra H, Polascik T.

J Endourol. 2010 May;24(5):775-80. doi: 10.1089/end.2009.0596.

PMID:
20477543
2.

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M.

BJU Int. 2014 Feb;113(2):218-27. doi: 10.1111/bju.12243.

3.

Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.

Smeenge M, Barentsz J, Cosgrove D, de la Rosette J, de Reijke T, Eggener S, Frauscher F, Kovacs G, Matin SF, Mischi M, Pinto P, Rastinehad A, Rouviere O, Salomon G, Polascik T, Walz J, Wijkstra H, Marberger M.

BJU Int. 2012 Oct;110(7):942-8. doi: 10.1111/j.1464-410X.2012.11072.x.

4.

Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.

Ahmed HU, Akin O, Coleman JA, Crane S, Emberton M, Goldenberg L, Hricak H, Kattan MW, Kurhanewicz J, Moore CM, Parker C, Polascik TJ, Scardino P, van As N, Villers A; Transatlantic Consensus Group on Active Surveillance and Focal Therapy for Prostate Cancer (appendix)..

BJU Int. 2012 Jun;109(11):1636-47. doi: 10.1111/j.1464-410X.2011.10633.x.

5.

Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU.

Eur Urol. 2015 Apr;67(4):771-7. doi: 10.1016/j.eururo.2014.09.018.

6.

Evaluating localized prostate cancer and identifying candidates for focal therapy.

Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT.

Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004.

PMID:
19095124
7.

Candidate selection for prostate cancer focal therapy.

Taneja SS, Mason M.

J Endourol. 2010 May;24(5):835-41. doi: 10.1089/end.2010.0006.

PMID:
20380491
8.

Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.

Muller BG, van den Bos W, Brausi M, Cornud F, Gontero P, Kirkham A, Pinto PA, Polascik TJ, Rastinehad AR, de Reijke TM, de la Rosette JJ, Ukimura O, Villers A, Walz J, Wijkstra H, Marberger M.

BJU Int. 2014 Nov;114(5):698-707. doi: 10.1111/bju.12548.

9.

Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.

van den Bos W, Muller BG, Ahmed H, Bangma CH, Barret E, Crouzet S, Eggener SE, Gill IS, Joniau S, Kovacs G, Pahernik S, de la Rosette JJ, Rouvière O, Salomon G, Ward JF, Scardino PT.

Eur Urol. 2014 Jun;65(6):1078-83. doi: 10.1016/j.eururo.2014.01.001.

PMID:
24444476
10.

Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.

Muller BG, van den Bos W, Brausi M, Fütterer JJ, Ghai S, Pinto PA, Popeneciu IV, de Reijke TM, Robertson C, de la Rosette JJ, Scionti S, Turkbey B, Wijkstra H, Ukimura O, Polascik TJ.

World J Urol. 2015 Oct;33(10):1503-9. doi: 10.1007/s00345-014-1475-2. Review.

PMID:
25559111
11.

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.

Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x.

12.

Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE").

Reis LO, Billis A, Zequi SC, Tobias-Machado M, Viana P, Cerqueira M, Ward JF.

Aging Male. 2014 Jun;17(2):66-71. doi: 10.3109/13685538.2014.895319. Review.

PMID:
24597940
13.

Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.

Tran M, Thompson J, Böhm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes AM, Savdie R, Stricker PD.

BJU Int. 2016 Jan;117(1):48-54. doi: 10.1111/bju.13090.

14.

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M.

Eur Urol. 2011 Apr;59(4):477-94. doi: 10.1016/j.eururo.2010.12.009.

PMID:
21195536
15.

How to select the right patients for focal therapy of prostate cancer?

Passoni NM, Polascik TJ.

Curr Opin Urol. 2014 May;24(3):203-8. doi: 10.1097/MOU.0000000000000045. Review.

PMID:
24625428
16.

Focal therapy for prostate cancer. Rationale, indications and selection.

Gómez-Veiga F, Portela-Pereira P, Cozar-Olmo JM, Ahmed H, Moore C, Dickinson L, Algaba F, Izquierdo L, Alcaraz Asensio A, Martinez-Breijo S, Emberton M.

Actas Urol Esp. 2014 Jul-Aug;38(6):405-12. doi: 10.1016/j.acuro.2013.12.005. Review. English, Spanish.

PMID:
24556193
17.

New treatments for localized prostate cancer.

Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL.

Urology. 2008 Dec;72(6 Suppl):S36-43. doi: 10.1016/j.urology.2008.08.506.

PMID:
19095127
18.

Contemporary results of focal therapy for prostate cancer using cryoablation.

Mouraviev V, Johansen TE, Polascik TJ.

J Endourol. 2010 May;24(5):827-34. doi: 10.1089/end.2009.0546. Review.

PMID:
20443724
19.

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L; International Task Force on Prostate Cancer and the Focal Lesion Paradigm..

J Urol. 2007 Dec;178(6):2260-7. Review.

PMID:
17936815
20.

Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?

Katz B, Srougi M, Dall'Oglio M, Nesrallah AJ, Sant'anna AC, Pontes J Jr, Reis ST, Sañudo A, Camara-Lopes LH, Leite KR.

Urol Oncol. 2012 Nov-Dec;30(6):794-7. doi: 10.1016/j.urolonc.2010.10.010.

PMID:
21458310
Items per page

Supplemental Content

Support Center